Vontobel Holding Ltd. Has $134,000 Stock Position in Teladoc Health, Inc. (NYSE:TDOC)

Vontobel Holding Ltd. lessened its holdings in Teladoc Health, Inc. (NYSE:TDOC) by 48.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 14,615 shares of the health services provider’s stock after selling 13,868 shares during the quarter. Vontobel Holding Ltd.’s holdings in Teladoc Health were worth $134,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of TDOC. Signaturefd LLC grew its position in Teladoc Health by 148.7% in the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock valued at $28,000 after acquiring an additional 1,715 shares during the last quarter. International Assets Investment Management LLC bought a new stake in shares of Teladoc Health during the 2nd quarter valued at approximately $29,000. SageView Advisory Group LLC acquired a new position in Teladoc Health during the 1st quarter worth approximately $48,000. Covestor Ltd lifted its stake in Teladoc Health by 58.1% in the 1st quarter. Covestor Ltd now owns 3,817 shares of the health services provider’s stock valued at $57,000 after purchasing an additional 1,403 shares during the last quarter. Finally, Doheny Asset Management CA acquired a new stake in Teladoc Health in the second quarter valued at approximately $46,000. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Price Performance

Shares of TDOC opened at $8.66 on Thursday. The firm has a market cap of $1.47 billion, a PE ratio of -6.14 and a beta of 0.91. Teladoc Health, Inc. has a 52-week low of $6.76 and a 52-week high of $22.54. The business’s 50 day moving average price is $8.24 and its two-hundred day moving average price is $9.92. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.62 and a current ratio of 1.66.

Teladoc Health (NYSE:TDOC) last released its earnings results on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.36) by $0.08. The company had revenue of $642.44 million for the quarter, compared to the consensus estimate of $649.34 million. Teladoc Health had a negative net margin of 38.54% and a negative return on equity of 10.25%. On average, equities analysts anticipate that Teladoc Health, Inc. will post -1.18 EPS for the current year.

Analysts Set New Price Targets

TDOC has been the subject of several research analyst reports. Canaccord Genuity Group lowered their price target on shares of Teladoc Health from $25.00 to $17.00 and set a “buy” rating for the company in a report on Thursday, August 1st. Barclays cut their price target on Teladoc Health from $20.00 to $10.00 and set an “overweight” rating on the stock in a research note on Thursday, August 1st. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $10.00 price objective on shares of Teladoc Health in a research note on Tuesday, August 20th. Truist Financial dropped their price objective on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating for the company in a report on Friday, August 2nd. Finally, TD Cowen reduced their target price on shares of Teladoc Health from $15.00 to $9.00 and set a “hold” rating on the stock in a report on Thursday, August 1st. Fifteen equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $11.81.

Insider Activity

In related news, COO Michael Willem Waters sold 6,053 shares of the company’s stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $49,271.42. Following the transaction, the chief operating officer now directly owns 74,214 shares of the company’s stock, valued at approximately $604,101.96. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, insider Vidya Raman-Tangella sold 3,857 shares of Teladoc Health stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $8.14, for a total transaction of $31,395.98. Following the completion of the transaction, the insider now directly owns 33,667 shares in the company, valued at $274,049.38. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Michael Willem Waters sold 6,053 shares of the company’s stock in a transaction dated Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $49,271.42. Following the completion of the sale, the chief operating officer now owns 74,214 shares in the company, valued at $604,101.96. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 57,377 shares of company stock worth $438,054 in the last three months. Company insiders own 0.95% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.